1. Home
  2. AMSC vs ODTX Comparison

AMSC vs ODTX Comparison

Compare AMSC & ODTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo American Superconductor Corporation

AMSC

American Superconductor Corporation

N/A

Current Price

$23.01

Market Cap

1.2B

ML Signal

N/A

Logo Odyssey Therapeutics Inc. Common Stock

ODTX

Odyssey Therapeutics Inc. Common Stock

N/A

Current Price

$19.14

Market Cap

1.3B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
AMSC
ODTX
Founded
1987
2021
Country
United States
United States
Employees
400
N/A
Industry
Metal Fabrications
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.3B
IPO Year
2012
2025

Fundamental Metrics

Financial Performance
Metric
AMSC
ODTX
Price
$23.01
$19.14
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
8
Target Price
★ $61.75
$35.33
AVG Volume (30 Days)
★ 743.4K
254.8K
Earning Date
11-04-2026
11-04-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 1806.25
N/A
EPS
★ 0.27
N/A
Revenue
★ $900,000.00
N/A
Revenue This Year
$22.95
N/A
Revenue Next Year
$15.15
N/A
P/E Ratio
$97.26
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$24.08
$15.10
52 Week High
$60.18
$29.05

Technical Indicators

Market Signals
Indicator
AMSC
ODTX
Relative Strength Index (RSI) 34.13 47.47
Support Level N/A $15.73
Resistance Level $32.24 $19.60
Average True Range (ATR) 1.77 1.75
MACD -0.21 0.18
Stochastic Oscillator 13.33 42.36

Price Performance

Historical Comparison
AMSC
ODTX

About AMSC American Superconductor Corporation

American Superconductor Corp generates the ideas, technologies, and solutions that meet the world's demand for smarter, cleaner, and energy. Through its Windtec Solutions, the company enables manufacturers to launch wind turbines quickly, effectively, and profitably. Through its Gridtec Solutions, the company provides engineering planning services and grid systems that optimize network reliability, efficiency, and performance. The company's segment includes Grid and Wind. It generates maximum revenue from the Grid segment.

About ODTX Odyssey Therapeutics Inc. Common Stock

Odyssey Therapeutics Inc is a clinical-stage biopharmaceutical company seeking to transform the standard of care for patients suffering from autoimmune and inflammatory diseases. The Company is developing medicines that are designed to precisely target disease pathology with an initial emphasis on the innate immune system. Its programs include OD-07656, a small molecule scaffolding inhibitor of receptor-interacting protein kinase 2, or RIPK2, a small molecule scaffolding inhibitor of interleukin-1 receptor-associated kinase 4, or IRAK4, and OD-00910, an agonistic protein therapeutic targeting tumor necrosis factor receptor 2, or TNFR2, built from camelid heavy chain variable regions, or VHH, domains.

Share on Social Networks: